Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dexcom (DXCM) Non Operating Income (2016 - 2025)

Dexcom (DXCM) has disclosed Non Operating Income for 10 consecutive years, with $17.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Non Operating Income fell 20.98% to $17.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $176.6 million, a 62.02% increase, with the full-year FY2025 number at $176.6 million, up 62.02% from a year prior.
  • Non Operating Income was $17.7 million for Q4 2025 at Dexcom, down from $109.8 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $109.8 million in Q3 2025 to a low of -$8.3 million in Q4 2021.
  • A 5-year average of $19.3 million and a median of $19.2 million in 2025 define the central range for Non Operating Income.
  • Peak YoY movement for Non Operating Income: tumbled 900.0% in 2022, then soared 2784.62% in 2023.
  • Dexcom's Non Operating Income stood at -$8.3 million in 2021, then grew by 28.92% to -$5.9 million in 2022, then soared by 613.56% to $30.3 million in 2023, then decreased by 26.07% to $22.4 million in 2024, then dropped by 20.98% to $17.7 million in 2025.
  • Per Business Quant, the three most recent readings for DXCM's Non Operating Income are $17.7 million (Q4 2025), $109.8 million (Q3 2025), and $28.5 million (Q2 2025).